Ameriprise’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-289,836
| Closed | -$858K | – | 3912 |
|
|
2024
Q2 | $858K | Hold |
289,836
| – | – | ﹤0.01% | 3214 |
|
|
2024
Q1 | $1.31M | Sell |
289,836
-50
| -0% | -$227 | ﹤0.01% | 3058 |
|
|
2023
Q4 | $1.66M | Sell |
289,886
-3,684
| -1% | -$21K | ﹤0.01% | 2966 |
|
|
2023
Q3 | $1.35M | Buy |
293,570
+341
| +0.1% | +$1.57K | ﹤0.01% | 3010 |
|
|
2023
Q2 | $1.89M | Buy |
293,229
+2,101
| +0.7% | +$13.6K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $2.2M | Buy |
291,128
+47,846
| +20% | +$361K | ﹤0.01% | 2803 |
|
|
2022
Q4 | $2.46M | Buy |
+243,282
| New | +$2.46M | ﹤0.01% | 2714 |
|
|
2021
Q2 | – | Sell |
-524,690
| Closed | -$17.8M | – | 3876 |
|
|
2021
Q1 | $17.8M | Buy |
524,690
+216,547
| +70% | +$7.35M | 0.01% | 1407 |
|
|
2020
Q4 | $12.4M | Buy |
+308,143
| New | +$12.4M | ﹤0.01% | 1579 |
|